267 related articles for article (PubMed ID: 9377108)
1. [The immunology of cholera and the molecular biology of cholera toxin. Recent progress and future perspectives].
Carrada-Bravo T
Rev Alerg Mex; 1994; 41(3):69-76. PubMed ID: 9377108
[TBL] [Abstract][Full Text] [Related]
2. [Cholera immunology and the molecular biology of cholera toxin. Recent progress and future prospects].
Carrada Bravo T
Rev Alerg; 1993; 40(4):91-4. PubMed ID: 8143024
[TBL] [Abstract][Full Text] [Related]
3. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
Svennerholm AM; Jertborn M; Gothefors L; Karim AM; Sack DA; Holmgren J
J Infect Dis; 1984 Jun; 149(6):884-93. PubMed ID: 6736680
[TBL] [Abstract][Full Text] [Related]
4. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
[TBL] [Abstract][Full Text] [Related]
5. Cholera and the immune response.
Holmgren J; Svennerholm AM
Prog Allergy; 1983; 33():106-19. PubMed ID: 6338509
[No Abstract] [Full Text] [Related]
6. Five-year immunologic memory in Swedish volunteers after oral cholera vaccination.
Jertborn M; Svennerholm AM; Holmgren J
J Infect Dis; 1988 Feb; 157(2):374-7. PubMed ID: 3335813
[No Abstract] [Full Text] [Related]
7. Intraduodenal inoculation of adult rabbits for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains.
García Imia L; Oliva Hernández R; Cedré Marrero B; Valmaseda Pérez T; García Sánchez H; Talavera Coronel A; Pérez Quiñoy JL; Sierra González G
Lab Anim Sci; 1998 Oct; 48(5):538-41. PubMed ID: 10090073
[No Abstract] [Full Text] [Related]
8. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
9. Specific antibodies to cholera toxin in rabbit milk are protective against Vibrio cholerae-induced intestinal secretion.
Yoshiyama Y; Brown WR
Immunology; 1987 Aug; 61(4):543-7. PubMed ID: 3443455
[TBL] [Abstract][Full Text] [Related]
10. Local and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humans.
Jertborn M; Nordström I; Kilander A; Czerkinsky C; Holmgren J
Infect Immun; 2001 Jun; 69(6):4125-8. PubMed ID: 11349086
[TBL] [Abstract][Full Text] [Related]
11. Local production of anti-vibrio cholerae mucosal antibody in reproductive tract tissues after cholera.
Ryan ET; Bridges EA; Crean TI; Gausia K; Hamadani JD; Aziz A; Hawkes S; Begum M; Bogaerts J; Faruque SM; Salam MA; Fuchs GJ; Calderwood SB
J Infect Dis; 2001 Sep; 184(5):643-7. PubMed ID: 11494170
[TBL] [Abstract][Full Text] [Related]
12. Antibodies against Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in the intestinal fluid during convalescence.
Chongsa-Nguan M; Chaicumpa W; Kalambaheti T; Surachedchai Y; Thanungkul B
Southeast Asian J Trop Med Public Health; 1987 Mar; 18(1):33-8. PubMed ID: 3660066
[TBL] [Abstract][Full Text] [Related]
13. Vibrio cholerae O1 vibriocidal and anti-cholera toxin antibodies in O139 Bengal cholera patients.
Takeda T; Ramamurthy T; Chowdhury AS; Dutta D; Bhattacharya SK; Deb BC; Nair GB; Takeda Y
J Infect; 1994 Sep; 29(2):233-5. PubMed ID: 7806891
[No Abstract] [Full Text] [Related]
14. Construction and characterization of a thyA mutant derived from cholera vaccine candidate IEM101.
Yu F; Qi G; Liu Y; Gao S; Kan B
Mol Biotechnol; 2005 Mar; 29(3):191-6. PubMed ID: 15767696
[TBL] [Abstract][Full Text] [Related]
15. Local immune response in mice to Vibrio cholerae.
Bloom LD; Rowley D
Aust J Exp Biol Med Sci; 1979 Jun; 57(3):313-23. PubMed ID: 394733
[TBL] [Abstract][Full Text] [Related]
16. The roles of mesoporous silica and carbon nanoparticles in antigen stability and intensity of immune response against recombinant subunit B of cholera toxin in a rabbit animal model.
Karimi Bavandpour A; Bakhshi B; Najar-Peerayeh S
Int J Pharm; 2020 Jan; 573():118868. PubMed ID: 31765785
[TBL] [Abstract][Full Text] [Related]
17. The role of antigen form and the induction of an intestinal immune response to cholera toxin/toxoid in rats.
Pierce NF
Adv Exp Med Biol; 1978; 107():439-45. PubMed ID: 742499
[No Abstract] [Full Text] [Related]
18. Oral vaccine against cholera prepared from Vibrio cholerae antigen(s).
Chaicumpa W; Chaisri U; Tapchaisri P; Chongsa-Nguan M; Pongponratn E
Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):142-8. PubMed ID: 3313733
[TBL] [Abstract][Full Text] [Related]
19. Immunisation against cholera with a Ty21a-cholera hybrid.
La Brooy JT; Forrest B; Bartholomeusz C
Ann Sclavo Collana Monogr; 1986; 3(1-2):143-7. PubMed ID: 3426872
[No Abstract] [Full Text] [Related]
20. Designing and Expression of Recombinant Chimeric Protein Containing CtxB and OmpW from Vibrio Cholerae and Evaluation of Its Immunogenicity.
Vakili A; Mousavi Gargari SL; Nazarian S; Amani J
Iran J Immunol; 2018 Sep; 15(3):207-220. PubMed ID: 30246696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
